Table 2. Prevalence Rate of Diagnoses by Class*.
| Diagnostic Cluster | Class 1 | Class 2 | Class 3 | Class 4 | Class 5 | Class 6 | Class 7 | Class 8 |
|---|---|---|---|---|---|---|---|---|
| Allergy | ||||||||
| 1-Asthma w/o Status Asthmaticus | 4.58% | 6.73% | 3.00% | 50.20% | 4.86% | 4.69% | 2.96% | 4.58% |
| 2-Allergic Rhinitis | 9.63% | 11.89% | 0.63% | 31.06% | 4.20% | 3.47% | 2.39% | 7.15% |
| 2-Asthma w/o Status Asthmaticus | 6.08% | 0.03% | 2.84% | 98.37% | 0.27% | 2.16% | 3.53% | 5.98% |
| Ear Nose Throat | ||||||||
| 1-Deafness hearing loss | 10.92% | 0.99% | 2.76% | 2.09% | 4.46% | 2.82% | 20.10% | 0.17% |
| 1-Chronic pharyngitis and tonsillitis | 33.05% | 0.29% | 0.16% | 0.93% | 0.79% | 0.56% | 0.62% | 0.07% |
| 1-ENT Disorders other | 7.53% | 0.40% | 0.87% | 0.81% | 1.32% | 0.94% | 2.29% | 0.17% |
| 2-Chronic pharyngitis and tonsillitis | 45.51% | 0.27% | 0.16% | 0.26% | 0.00% | 0.19% | 0.10% | 0.34% |
| 3-Chronic pharyngitis and tonsillitis | 33.99% | 0.32% | 0.39% | 0.67% | 0.06% | 0.38% | 0.62% | 0.48% |
| Gastrointestinal/Hepatic | ||||||||
| 1-Constipation | 0.73% | 1.82% | 1.34% | 1.63% | 0.17% | 47.07% | 1.87% | 1.81% |
| 1-Gasteroenteritis | 0.60% | 1.84% | 0.63% | 0.73% | 0.12% | 1.97% | 1.30% | 22.56% |
| 2-Constipation | 1.63% | 1.68% | 1.58% | 1.88% | 0.00% | 61.76% | 4.31% | 1.98% |
| 2-Gastroesophageal reflux | 3.17% | 0.61% | 3.55% | 3.18% | 1.15% | 8.82% | 4.21% | 1.71% |
| General Signs and Symptoms | ||||||||
| 1-Fever | 1.28% | 1.63% | 2.29% | 2.42% | 0.24% | 1.78% | 0.31% | 30.02% |
| 1-Nausea vomiting | 0.34% | 0.00% | 0.71% | 0.42% | 0.00% | 1.88% | 0.36% | 20.00% |
| Genito-Urinary | ||||||||
| 1-Urinary Symptoms | 1.50% | 1.34% | 0.39% | 1.74% | 2.15% | 18.58% | 0.68% | 0.51% |
| 2-Urinary Symptoms | 1.28% | 1.66% | 0.39% | 1.16% | 2.20% | 17.60% | 0.36% | 1.71% |
| Neurologic | ||||||||
| 1-Headaches | 0.43% | 0.11% | 0.39% | 1.09% | 0.09% | 0.23% | 0.57% | 28.10% |
| 1-Seizure Disorder | 0.47% | 0.16% | 62.32% | 0.22% | 0.10% | 0.80% | 0.57% | 0.96% |
| 1-Sleep Problems | 21.79% | 0.24% | 0.87% | 0.20% | 0.23% | 0.38% | 1.77% | 0.24% |
| 1-Autism Spectrum Disorder | 0.09% | 0.11% | 3.16% | 0.20% | 0.02% | 0.23% | 26.81% | 0.03% |
| 2-Neurologic signs and symptoms | 1.84% | 0.61% | 10.19% | 0.59% | 1.54% | 1.50% | 11.12% | 2.19% |
| 2-Headaches | 1.11% | 0.96% | 2.05% | 0.76% | 0.40% | 0.28% | 1.14% | 21.81% |
| 2-Seizure Disorder | 0.68% | 0.11% | 79.15% | 0.08% | 0.03% | 0.23% | 1.35% | 0.82% |
| 2-Sleep Problems | 22.35% | 0.29% | 0.95% | 0.40% | 0.31% | 0.80% | 5.09% | 1.57% |
| 2-Developmental disorder | 3.42% | 2.30% | 17.69% | 1.95% | 2.37% | 3.00% | 49.82% | 2.29% |
| 2-Autism Spectrum Disorder | 0.47% | 0.05% | 4.82% | 0.61% | 0.01% | 0.84% | 47.12% | 0.38% |
| 3-Seizure Disorder | 0.47% | 0.27% | 46.84% | 0.16% | 0.07% | 0.19% | 0.78% | 0.10% |
| 3-Sleep Problems | 17.81% | 0.48% | 0.55% | 0.40% | 0.07% | 0.00% | 2.08% | 0.55% |
| 3-Developmental disorder | 2.31% | 1.15% | 10.82% | 0.70% | 1.15% | 1.13% | 36.21% | 1.20% |
| 3-Autism Spectrum Disorder | 0.39% | 0.21% | 2.29% | 0.09% | 0.00% | 0.47% | 29.87% | 0.27% |
| Respiratory | ||||||||
| 1-Respiratory signs and symptoms | 11.90% | 2.35% | 1.26% | 4.72% | 1.85% | 1.50% | 0.88% | 1.33% |
| 1-Sleep Apnea | 23.54% | 0.29% | 1.18% | 0.84% | 0.43% | 0.75% | 0.42% | 0.00% |
| 2-Respiratory signs and symptoms | 12.37% | 4.25% | 1.34% | 4.33% | 1.68% | 1.36% | 1.25% | 2.80% |
| 2-Sleep Apnea | 26.50% | 0.00% | 0.79% | 0.99% | 0.03% | 0.61% | 0.36% | 0.44% |
| 3-Sleep Apnea | 19.82% | 0.16% | 0.87% | 0.40% | 0.03% | 0.33% | 0.99% | 0.55% |
| Skin | ||||||||
| 1-Dermatitis and eczema | 1.54% | 54.21% | 0.32% | 9.28% | 0.42% | 1.41% | 2.13% | 0.58% |
| 2- Dermatitis and eczema | 2.40% | 60.65% | 1.66% | 13.68% | 0.08% | 0.89% | 2.86% | 3.04% |
* Highlighted prevalence rates are those greater than or equal to 10%.